CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Dec 13, 2016 · 10-K · 104 days after period end · 0001683168-16-000925
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$78.52K | -$204.54K | -$168.62K | -$31.91K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Aug 31, 2016 · filed Dec 13, 2016 · 104 d after period end
